These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32094505)

  • 21. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
    Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N
    Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developing a low-cost and accessible COVID-19 vaccine for global health.
    Hotez PJ; Bottazzi ME
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008548. PubMed ID: 32726304
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccine designers take first shots at COVID-19.
    Cohen J
    Science; 2020 Apr; 368(6486):14-16. PubMed ID: 32241928
    [No Abstract]   [Full Text] [Related]  

  • 24. Rational Vaccine Design in the Time of COVID-19.
    Burton DR; Walker LM
    Cell Host Microbe; 2020 May; 27(5):695-698. PubMed ID: 32407707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Audio Interview: Vaccinology and Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(16):e109. PubMed ID: 33053301
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A systematic review.
    Noorimotlagh Z; Karami C; Mirzaee SA; Kaffashian M; Mami S; Azizi M
    Int Immunopharmacol; 2020 Sep; 86():106738. PubMed ID: 32683296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 immunogenicity at the crossroads.
    Karamloo F; König R
    Allergy; 2020 Jul; 75(7):1822-1824. PubMed ID: 32401346
    [No Abstract]   [Full Text] [Related]  

  • 28. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.
    Zhang BZ; Hu YF; Chen LL; Yau T; Tong YG; Hu JC; Cai JP; Chan KH; Dou Y; Deng J; Wang XL; Hung IF; To KK; Yuen KY; Huang JD
    Cell Res; 2020 Aug; 30(8):702-704. PubMed ID: 32612199
    [No Abstract]   [Full Text] [Related]  

  • 29. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
    Palatnik-de-Sousa CB
    Front Immunol; 2020; 11():2173. PubMed ID: 32983183
    [No Abstract]   [Full Text] [Related]  

  • 30.
    Lee CH; Koohy H
    F1000Res; 2020; 9():145. PubMed ID: 32269766
    [No Abstract]   [Full Text] [Related]  

  • 31. Energetics and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development.
    Banerjee A; Santra D; Maiti S
    J Transl Med; 2020 Jul; 18(1):281. PubMed ID: 32650788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19.
    Ojha R; Gupta N; Naik B; Singh S; Verma VK; Prusty D; Prajapati VK
    Eur J Pharm Sci; 2020 Aug; 151():105375. PubMed ID: 32417398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A strategic approach to COVID-19 vaccine R&D.
    Corey L; Mascola JR; Fauci AS; Collins FS
    Science; 2020 May; 368(6494):948-950. PubMed ID: 32393526
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies.
    Hussain A; Hasan A; Nejadi Babadaei MM; Bloukh SH; Chowdhury MEH; Sharifi M; Haghighat S; Falahati M
    Biomed Pharmacother; 2020 Oct; 130():110559. PubMed ID: 32768882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach.
    Ahammad I; Lira SS
    Int J Biol Macromol; 2020 Nov; 162():820-837. PubMed ID: 32599237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies.
    Papageorgiou AC; Mohsin I
    Cells; 2020 Oct; 9(11):. PubMed ID: 33105869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
    van Doremalen N; Lambe T; Spencer A; Belij-Rammerstorfer S; Purushotham JN; Port JR; Avanzato VA; Bushmaker T; Flaxman A; Ulaszewska M; Feldmann F; Allen ER; Sharpe H; Schulz J; Holbrook M; Okumura A; Meade-White K; Pérez-Pérez L; Edwards NJ; Wright D; Bissett C; Gilbride C; Williamson BN; Rosenke R; Long D; Ishwarbhai A; Kailath R; Rose L; Morris S; Powers C; Lovaglio J; Hanley PW; Scott D; Saturday G; de Wit E; Gilbert SC; Munster VJ
    Nature; 2020 Oct; 586(7830):578-582. PubMed ID: 32731258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2.
    Zhang Y; Kutateladze TG
    Nat Commun; 2020 Jun; 11(1):2920. PubMed ID: 32523109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.
    Yi Z; Ling Y; Zhang X; Chen J; Hu K; Wang Y; Song W; Ying T; Zhang R; Lu H; Yuan Z
    Emerg Microbes Infect; 2020 Dec; 9(1):1988-1996. PubMed ID: 32844713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.